One six-month, randomized, double-blinded, placebo-controlled trial found that taking oral glutathione at either 250 or 1,000 mg/day led to significant increases in the body stores of glutathione in a dose-dependent manner
GLP-1 receptor agonists slow gastric emptying, which has been hypothesized to affect pancreatic function, though this connection remains speculative and lacks supporting clinical evidence
The reclassification of BPC-157, TB-500, KPV, MOTs-c, and GHK-Cu underscores the FDA's commitment to safety and evidence-based practice
The STEP 8 trial by Rubino et al
Ultimately, we think that Alpha BRAIN is reasonably priced for a nootropic, but it has some issues with its formulation and how it presents itself to consumers, which gives us pause